Who sells to Cencora
11 listed companies name Cencora as a customer behind 10% or more of their revenue, led by Bristol Myers Squibb at 29%.
Each share is of the supplier’s own revenue: how much of its business Cencora is. Cencora's own customers and margins
Suppliers that name Cencora
Cencora as a share of each supplier's revenue, largest first.
| Supplier | Of its revenue | Annual report |
|---|---|---|
| BMYBristol Myers Squibb | 29% | FY2025 10-K |
| AMPHAmphastar Pharmaceuticals | 22% | FY2025 10-K |
| EXELExelixis | 22% | FY2025 10-K |
| PCRXPacira BioSciences | 22% | FY2025 10-K |
| ALKSAlkermes | 20% | FY2025 10-K |
| RIGLRigel Pharmaceuticals | 19% | FY2025 10-K |
| BHCBausch Health Companies | 18% | FY2025 10-K |
| ARDXArdelyx | 17% | FY2025 10-K |
| PFEPfizer | 16% | FY2025 10-K |
| ELANElanco Animal Health | 12% | FY2025 10-K |
| VTRSViatris | 11% | FY2025 10-K |
A US company has to name every customer behind 10% or more of its revenue in its annual report. This page lists the listed companies whose latest 10-K, 20-F or 40-F names Cencora that way. Suppliers below the 10% line, private suppliers and suppliers that keep the customer anonymous do not appear. Who depends on whom has the same disclosures across every company.